7,8-Dihydroneopterin-induced apoptosis in Jurkat T lymphocytes: A comparison with anti-Fas- and hydrogen peroxide-mediated cell death

Biochemical Pharmacology

Volumn 56, Issue 9, 1998, Pages 1181-1187

  Wirleitner, Barbara ^a   Baier Bitterlich, Gabriele ^a   Böck, Günther ^a   Widner, Bernhard ^a   Fuchs, Dietmar ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

7,8 dihydroneopterin; Apoptosis; Fas; Hydrogen peroxide; Pteridines; Reactive oxygen intermediates

Indexed keywords

7,8 DIHYDRONEOPTERIN; ANTIBODY; CYCLOHEXIMIDE; CYCLOSPORIN A; DACTINOMYCIN; FAS ANTIGEN; HYDROGEN PEROXIDE; NEOPTERIN; OXYGEN RADICAL; PROTEIN KINASE INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA CELL LINE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS ACTIVATION;

ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; HUMANS; HYDROGEN PEROXIDE; JURKAT CELLS; NEOPTERIN; PHOSPHORYLATION; PTERIDINES; TYROSINE;

EID: 0031773481     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00168-3     Document Type: Article

References (50)

1. Nathan CF, Secretory products of macrophages. J Clin Invest 79: 319-326,1987.
2. Billiau A and Dijkmans R, Interferon-γ, mechanisms of action and therapeutic potential. Biochem Pharmacol 40: 1433-1439, 1990.
3. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J and Wachter H, Immune response- associated production of neopterin. J Exp Med 160: 310-316, 1984.
4. Bitterlich G, Szabo G, Werner ER, Larcher C, Fuchs D, Hausen A, Reibnegger G, Schulz TF, Troppmair J and Wachter H, Selective induction of mononuclear phagocytes to produce neopterin by interferons. Immunobiol 176: 228-235, 1988.
5. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G and Wachter H, Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-γ. Biochem J 262: 861-866, 1989.
6. Fuchs D, Malkovsky M, Reibnegger G, Werner ER, Forni G and Wachter H, Endogenous release of interferon-γ and diminished response of peripheral blood mononuclear cells to antigenic stimulation. Immunol Lett 23: 103-108, 1989.
7. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP and Wachter H, Neopterin as a marker for activated cell-mediated immunity: Application in HIV infection. Immunol Today 9: 150-155, 1988.
8. Wachter H, Fuchs D, Hausen A, Reibnegger G and Werner ER, Neopterin as a marker for activation of cellular immunity: Immunologic basis and clinical application. Adv Clin Chem 27: 81-141, 1989.
9. Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss G, Werner E and Werner-Felmayer G, Neopterin. Walter de Gruyter, Berlin, New York, 1992.
10. Weiss G, Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Semenitz E, Dierich MP and Wachter H, Neopterin modulates toxicity by reactive oxygen and chloride species. FEBS Lett 321: 89-92, 1993.
11. Murr C, Fuchs D, Gössler W, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Esterbaur H, and Wachter, H, Enhancement of hydrogen peroxide-induced luminol-dependent chemiluminescence by neopterin depends on the presence of iron chelator complexes. FEBS Lett 338: 223-226, 1994.
12. Reibnegger G, Fuchs D, Murr C, Dierich MP, Pfleiderer W and Wachter H, Effects of pteridines on luminol-dependent chemiluminescence induced by chloramine-T. Free Rad Biol Med 18: 515-523, 1995.
13. Baier-Bitterlich G, Fuchs D, Murr C, Reibnegger G, Werner-Felmayer G, Sgonc R, Bock G, Dierich MP and Wachter H, Effect of neopterin and 7,8-dihydroneopterin on tumor necrosis factor tumor necrosis factor-γ induced programmed cell death. FEBS Lett 364: 234-238, 1995.
14. Baier-Bitterlich G, Fuchs D, Zangerle R, Baeuerle PA, Werner ER, Fresser F, Überall F, Baier G and Wachter H, trans-Activation of the HIV-1 promoter by 7,8-dihydroneopterin in vitro. AIDS Res Human Retrovir 13: 173-178, 1997.
15. Baier-Bitterlich G, Baier G, Fuchs D, Bock G, Hausen A, Utermann G, Pavelka M and Wachter H, Role of 7,8-dihydroneopterin in T-cell apoptosis and HTLV-1 transcription in vitro. Oncogene 13: 2281-2285, 1996.
16. Hoffmann G, Schobersberger W, Grote J, Wachter H. and Fuchs D, Neopterin induces translocation of the p50/Rel-A dimer of nuclear factor (B to the nucleus of vascular smooth muscle cells in vitro. FEBS Lett 391: 181-184, 1996.
17. Gougeon ML and Montagnier L, Apoptosis in AIDS, Science 260: 1269-70, 1993.
18. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP and Finkel TH, Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176: 1099-1106, 1992.
19. Cohen DI, Tani Y, Tian H, Boone E, Samelson LE and Lane HC, Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1. Science 256: 542-545, 1992.
20. Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS and Pahwa S, Accelerated apoptosis in peripheral blood mononuclear (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82: 3392-3400, 1993.
21. Laurent-Crawford AG, Krust B, Muller S, Riviere Y, Rey-Cuille MA, Bechet JM, Montagnier L and Hovanessian AG, The cytopathic effect of HIV is associated with apoptosis. Virology 185: 829-839, 1991.
22. Tian H, Kolesnitchenko V, Donoghue E, Shaw G, Lane C and Cohen D, HIV envelope-directed CD4 T-cell degeneration represents a novel cell death program, Abstr. In: The First National Conference on Human Retroviruses and Related Infections, pp. 275. American Society for Microbiology, Washington D.C., 1993.
23. Debatin KM, Fahrig-Faissner A, Enenkel-Stoodt S, Kreuz W, Benner A and Krammer PH, High expression of APO-1 (CD95) on T lymphocytes from human immunodeficency virus-1-infected children. Blood 83: 3101-3103, 1994.
24. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA and Herzenberg LA, Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 181: 2029-2036, 1995.
25. +T cells from HIV-infected patients increases with disease progression. J Mol Med 73: 591-593, 1995.
26. Schreck R, Grassmann R, Fleckenstein B. and Baeuerle PA, Antioxidants selectively suppress activation of NF-κB by human T-cell leukemia virus type I Tax protein. J Virol 66: 6288-6293, 1992.
27. Schreck R, Rieber P. and Baeuerle PA, Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
28. Greenspan HC and Aruoma OI, Oxidative stress and apoptosis in HIV infection: A role for plant-derived metabolites with synergistic antioxidant activity. Immunol Today 15: 209-213, 1994.
29. Droge W, Eck HP and Mihm S, HIV-induced cysteine deficiency and T-cell dysfunction - A rationale for treatment with N-acetylcysteine. Immunol Today 13: 211-213, 1992.
30. Buttke TM and Sandstrom PA, Oxidative stress as a mediator of apoptosis. Immunol Today 15: 7-10, 1994.
31. Baier-Bitterlich G, Fuchs D and Wachter H, Chronic immune stimulation, oxidative stress, and apoptosis in HIV infection. Biochem Pharmacol 53: 755-763, 1997.
32. Migliorati G, Nicoletti I, Pagliacci, MC, Crocicchio F, Tognellini R and Riccardi C, Interactions between glucocorticoid hormones and interleukins in T cell development: Another possible link between neuroendocrine and immune systems. Acta Neurol 13: 350-355, 1991.
33. Sgonc R and Wick G, Methods for the detection of apoptosis. Int Arch Allergy and Immunol 105: 327-332, 1994.
34. Gulbins E, Bissonnette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A and Green D, Fas-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2: 341-351, 1995.
35. Hansson M, Asea A, Ersson U, Hermodsson S and Hellstrand K, Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. J Immunol 156: 42-47, 1996.
36. Chow SC, Weis M, Kass GE, Holmström TH, Eriksson JE and Orrenius S, Involvement of multiple proteases during Fas-mediated apoptosis in T lymphocytes. FEBS Lett 364: 134-138, 1995.
37. Clement MV and Stamenkovic I, Superoxide anion is a natural inhibitor of FAS-mediated cell death. EMBO 15: 216-225, 1996.
38. Eischen CM, Dick CJ and Leibson PJ, Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 153: 1947-1954, 1994.
39. Hunter T and Karin M, The regulation of transcription by phosphorylation. Cell 70: 375-387, 1992.
40. Roveri A, Coassin M, Maiorino M, Zamburlini A, van Amsterdam FT, Ratti E and Ursini F, Effect of hydrogen peroxide on calcium homeostasis in smooth muscle cells. Arch Biochem Biophys 297: 265-270, 1992.
41. Wöll E, Weiss G, Fuchs D, Lang F and Wachter H, Effect of pteridine derivatives on intracellular calcium concentration in human monocytic cells. FEBS Lett 318: 249-252, 1993.
42. Schraven B and Peter ME, APO-1 (CD95)-mediated apoptosis in Jurkat cells does not involve src kinases or CD45. FEBS Lett 368: 491-494, 1995.
43. Suzuki Y J, Forman HJ and Sevanian A, Oxidants as stimulators of signal transduction. Free Radical Biol Med 22: 269-285, 1997.
44. Whisler RL, Goyette MA, Grants IS. and Newhouse YG, Sublethal levels of oxidant stress stimulate multiple serine/ threonine kinases and suppress protein phosphatases in Jurkat T cells. Arch of Biochem Biophys 319: 23-35, 1995.
45. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12: 2005-2015, 1993.
46. Chang DJ, Ringold GM and Heller RA, Cell killing and induction of manganous superoxide dismutase by tumor necrosis factor-α is mediated by lipoxygenase metabolites of arachidonic acid. Biochem Biophys Res Commun 188: 538-546, 1992.
47. Verhaegen S, McGowan AJ, Brophy AR, Fernandes RS and Cotter TG, Inhibition of apoptosis by antioxidants in the human HL-60 leukemia cell line. Biochem Pharmacol 50: 1021-1029, 1995.
48. Um H-D, Orenstein JM and Wahl SM, Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway. J Immunol 156: 3469-3477, 1996.
49. Delneste Y, Jeannin P, Sebille E, Aubry JP and Bonnefoy J-Y, Thiols prevent Fas (CD95)-mediated T cell apoptosis by down-regulating membrane Fas expression. Eur J Immunol 26: 2981-2988, 1996.
50. Hug H, Enari M and Nagata S, No requirement of reactive oxygen intermediates in Fas-mediated apoptosis. FEBS Lett 351: 311-313, 1994.